Moneycontrol PRO
HomeNewsTriveniturbine
Jump to
  • Buy Thyrocare Technologies; target of Rs 1560: ICICI Securities

    ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1560 in its research report dated October 15, 2025.

  • Buy Thyrocare Technologies; target of Rs 1000: ICICI Securities

    Buy Thyrocare Technologies; target of Rs 1000: ICICI Securities

    ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 1000 in its research report dated April 24, 2025.

  • Buy Thyrocare Technologies; target of Rs 825: ICICI Securities

    Buy Thyrocare Technologies; target of Rs 825: ICICI Securities

    ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 825 in its research report dated July 24, 2024.

  • Buy Thyrocare Technologies; target of Rs 750: ICICI Securities

    Buy Thyrocare Technologies; target of Rs 750: ICICI Securities

    ICICI Securities is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 15, 2024.

  • Buy Thyrocare Technologies; target of Rs 740: ICICI Securities

    Buy Thyrocare Technologies; target of Rs 740: ICICI Securities

    ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.

  • Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

    Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

    Going forward, technology will be the differentiator, and Vijay Diagnostic's differentiated hub- and-spoke model calls for attention

  • Vijaya Diagnostic IPO: Can this regional player repeat the success of KIMS IPO?

    Vijaya Diagnostic IPO: Can this regional player repeat the success of KIMS IPO?

    The key strength of Vijaya Diagnostic lies in its heavy B2C mix – more than 90 per cent of business flows from individual customers. This ensures that the company has almost negligible receivables which helps it to maintain a negative working capital.

  • Krsnaa Diagnostics IPO: Should one foot the bill for this diagnostics?

    Krsnaa Diagnostics IPO: Should one foot the bill for this diagnostics?

    The key differentiator in the business model of Krsnaa Diagnostics is the hub-and-spoke model in radiology

  • Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher

    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher

    Prabhudas Lilladher is bearish on Thyrocare Technologies has recommended sell rating on the stock with a target price of Rs 307 in its research report dated August 04, 2020.

  • Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher

    Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher

    Prabhudas Lilladher is bearish on Thyrocare Technologies has recommended sell rating on the stock with a target price of Rs 307 in its research report dated May 27, 2020.

  • Buy Thyrocare Technologies; target of Rs 686: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 686: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 686 in its research report dated November 08, 2019.

  • Buy Thyrocare Technologies; target of Rs 595: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 595: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 595 in its research report dated August 14, 2019.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated February 12, 2019.

  • Buy Thyrocare Technologies; target of Rs 796: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 796: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 796 in its research report dated November 12, 2018.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 14, 2018.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 06, 2018.

  • Buy Thyrocare Technologies; target of Rs 750: Edelweiss

    Buy Thyrocare Technologies; target of Rs 750: Edelweiss

    Edelweiss is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 03, 2018.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated May 04, 2018.

  • Buy Thyrocare Technologies; target of Rs 740: Edelweiss

    Buy Thyrocare Technologies; target of Rs 740: Edelweiss

    Edelweiss is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 12, 2017.

  • Buy Thyrocare Tech; target of Rs 1067: Prabhudas Lilladher

    Buy Thyrocare Tech; target of Rs 1067: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 1067 in its research report dated November 17, 2016.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347